StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson non-GAAP adjusted diluted net earnings per share ($) ($)

Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings

Latest, FY2025
10.79
Period ended Dec 28, 2025
Change on a year earlier
+8.1%
9.98 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up non-gaap adjusted diluted net earnings per share ($)

Cite this data

StockData. (2026). Johnson & Johnson Non-GAAP adjusted diluted net earnings per share ($) ($), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj_eps_diluted

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.